01/16/2025
3:49 PM | Flagship Pioneering Fund VII, L.P. (Reporting)
Syros Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2025
3:01 PM | Syros Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/30/2024
4:11 PM | AKKARAJU SRINIVAS (Reporting)
Syros Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/27/2024
3:02 PM | Flagship Pioneering Fund VII, L.P. (Reporting)
Syros Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/13/2024
3:17 PM | Flagship VentureLabs IV, LLC (Reporting)
Syros Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/10/2024
2:01 PM | Syros Pharmaceuticals (Subject)
Young Richard A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2024
6:00 AM | Syros Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/25/2024
4:59 PM | Simonian Nancy A (Reporting)
Syros Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/19/2024
4:22 PM | Quirk Gerald E (Reporting)
Syros Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/18/2024
4:42 PM | Roth David (Reporting)
Syros Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/18/2024
5:00 PM | Haas Jason (Reporting)
Syros Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
11/18/2024
4:20 PM | Stephens Kristin (Reporting)
Syros Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/18/2024
3:45 PM | Chee Conley (Reporting)
Syros Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/18/2024
3:18 PM | Haas Jason (Reporting)
Syros Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/18/2024
11:08 AM | Chee Conley (Reporting)
Syros Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/18/2024
6:01 AM | Syros Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
4:24 PM | Bain Capital Life Sciences Fund II, L.P. (Filed by)
Syros Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/14/2024
4:28 PM | Avidity Partners Management LP (Filed by)
Syros Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/13/2024
6:00 AM | Syros Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
4:00 PM | Stephens Kristin (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/04/2024
4:01 PM | Chee Conley (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/04/2024
4:01 PM | Haas Jason (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/04/2024
4:01 PM | Roth David (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/04/2024
4:01 PM | Simonian Nancy A (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2024
5:49 AM | Syros Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/02/2024
4:00 PM | Quirk Gerald E (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
4:00 PM | Syros Pharmaceuticals (Issuer)
Young Richard A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
4:00 PM | AKKARAJU SRINIVAS (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
4:00 PM | Chee Conley (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
4:00 PM | Haas Jason (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:01 AM | Syros Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
4:03 PM | Syros Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/02/2024
5:39 PM | Invus Global Management, LLC (Filed by)
Syros Pharmaceuticals (Subject)
| Form SC 13G/A | |
07/31/2024
6:44 AM | Syros Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/31/2024
5:55 AM | Syros Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/07/2024
3:30 PM | Syros Pharmaceuticals (Issuer)
WIRTH PETER (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:30 PM | AKKARAJU SRINIVAS (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:30 PM | Fanucci Marsha (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:30 PM | OH ANDREW M. (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:30 PM | Eckhardt Sue Gail (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:30 PM | Dunsire Deborah (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
I was wrong. Dead wrong. (Ad) I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was.
Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.  Here’s the full story for you. |
06/07/2024
3:30 PM | Syros Pharmaceuticals (Issuer)
TYSON TIMOTHY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:30 PM | Syros Pharmaceuticals (Issuer)
Young Richard A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:30 PM | Simonian Nancy A (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
3:30 PM | Syros Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2024
3:41 PM | AKKARAJU SRINIVAS (Reporting)
AKKARAJU SRINIVAS (Reporting)
Syros Pharmaceuticals (Issuer)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
5:42 AM | Syros Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/23/2024
6:01 AM | Syros Pharmaceuticals (Filer)
| Form DEF 14A | |
04/23/2024
6:05 AM | Syros Pharmaceuticals (Filer)
| Form DEFA14A | |
04/23/2024
6:10 AM | Syros Pharmaceuticals (Filer)
| Form ARS | |
04/12/2024
3:30 PM | Syros Pharmaceuticals (Filer)
| Form PRE 14A | |
04/05/2024
3:30 PM | Roth David (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
3:54 PM | Haas Jason (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
3:57 PM | Quirk Gerald E (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
3:58 PM | Roth David (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
3:59 PM | Simonian Nancy A (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
4:01 PM | Stephens Kristin (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
3:14 PM | Roth David (Reporting)
Syros Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/27/2024
6:04 AM | Syros Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/27/2024
5:49 AM | Syros Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
7:56 PM | Blue Owl Capital Holdings LP (Filed by)
Syros Pharmaceuticals (Subject)
| Form SC 13G | |
02/13/2024
7:22 PM | Avidity Partners Management LP (Filed by)
Syros Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/13/2024
5:59 PM | Bain Capital Life Sciences Fund II, L.P. (Filed by)
Syros Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/13/2024
6:02 PM | Ally Bridge MedAlpha Master Fund L.P. (Filed by)
Syros Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/09/2024
4:08 PM | Artal International S.C.A. (Filed by)
Syros Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/07/2024
6:09 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Syros Pharmaceuticals (Subject)
| Form SC 13G/A | |
